The founder of Lessonia, a company specializing in the shaping of cosmetic products and the manufacture of natural ingredients for cosmetic brands, is selling the majority of his shares in order to develop the company’s shareholding around a team of managers, led by Sébastien Guillotin. Lessonia’s management thus becomes the majority shareholder.

This operation is combined with an entry into the capital of minority investors, NewAlpha Verto, Bpifrance and BNP Paribas Développement, in order to support Lessonia in the new stage of its development.

Jérémie Swiecznik, partner, was involved in this transaction.

Degroux Brugère advised Bpifrance and Kurma Partners, historical investors of Kiro, a company specialized in digital medicine, in its €13.8 million Series A financing round.

The round was led by Sofinnova Partners. The historical investors, the Ambition Amorçage Angels (F3A) fund of France 2030, managed on behalf of the French government by Bpifrance and Kurma Partners, also participated in the financing alongside Propulia Capital, entrepreneurs and European and American business angels.

Thanks to this investment, the Marseille-based start-up is now in a position to develop its artificial intelligence platform for interpreting medical examinations, and also to expand internationally.

This transaction was carried out by DEGROUX BRUGERE with Jérémie Swiecznik, partner.